# Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma

> **NCT00912847** · — · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 1018 (actual)

## Conditions studied

- Hepatitis B Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00912847
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1997-10
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 1018 (ACTUAL)
- **Last updated:** 2009-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00912847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00912847, "Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00912847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*